Nasdaq-100 ETFs compared: returns and risk
Funds that track the Nasdaq-100: the 100 largest non-financial companies listed on the Nasdaq, heavy in technology.
Data updated October 2026
| Fund | 1Y | 3Y a yr | 5Y a yr | 10Y a yr | Volatility | Max drawdown | Since |
|---|---|---|---|---|---|---|---|
 QQQInvesco QQQ Trust | +19.5% | +26.6% | +14.5% | +20.6% | 22.1% | −53.4% | 2006 |
| QQQMInvesco NASDAQ 100 ETF | +19.6% | +26.7% | +14.6% | — | 22.3% | −35.0% | 2021 |
 EQQQInvesco EQQQ Nasdaq-100 UCITS ETF (Dist) | +26.0% | +23.5% | +15.0% | +19.6% | 19.7% | −31.5% | 2010 |
| CSNDXiShares NASDAQ 100 UCITS ETF (Acc) | +26.3% | +23.8% | +15.4% | +20.2% | 21.2% | −31.2% | 2010 |
| ONEQFidelity Nasdaq Composite Index ETF | +17.3% | +27.0% | +12.9% | +18.1% | 21.6% | −55.5% | 2006 |
Total returns with dividends reinvested, in each fund’s trading currency, to the last close; periods longer than a year are annualised. Volatility and maximum drawdown cover each fund’s whole history since the year shown, so they are comparable only between funds with similar start dates.
Head-to-head comparisons
Other ETF categories
- S&P 500 ETFs
- Total US stock market ETFs
- Dow Jones and equal-weight ETFs
- US small and mid cap ETFs
- US growth ETFs
- US value ETFs
- Small cap value and growth ETFs
- Dividend ETFs
- Covered call and equity income ETFs
- Factor ETFs (min vol, quality, momentum, value)
- World and all-world ETFs
- International developed markets ETFs
- Europe ETFs
- Emerging markets and Asia ETFs
- Technology and semiconductor ETFs
- US sector ETFs
- Real estate (REIT) ETFs
- Thematic ETFs
- US Treasury bond ETFs
- Inflation-linked bond ETFs
- Aggregate bond ETFs
- Corporate, high yield and municipal bond ETFs
- Cash and T-bill ETFs
- Gold and precious metals ETFs
- Oil, gas and commodity ETFs
- Bitcoin and crypto ETFs
- Leveraged and inverse ETFs
- Allocation and multi-asset ETFs
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.